American International Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10
Closed 3218
2017
Q1
$0 Sell
10
-11,421
-100% -$62K ﹤0.01% 3062
2016
Q4
$56K Sell
11,431
-30
-0.3% -$154 ﹤0.01% 2833
2016
Q3
$56.8K Buy
11,461
+17
+0.1% +$87 ﹤0.01% 2862
2016
Q2
$58.3K Buy
11,444
+175
+2% +$942 ﹤0.01% 2908
2016
Q1
$65K Hold
11,269
﹤0.01% 3724
2015
Q4
$117K Sell
11,269
-20
-0.2% -$271 ﹤0.01% 3367
2015
Q3
$209K Buy
11,289
+13
+0.1% +$251 ﹤0.01% 2778
2015
Q2
$219K Sell
11,276
-749
-6% -$13.3K ﹤0.01% 2922
2015
Q1
$211K Hold
12,025
﹤0.01% 2898
2014
Q4
$192K Sell
12,025
-472
-4% -$6.32K ﹤0.01% 2976
2014
Q3
$157K Sell
12,497
-9
-0.1% -$128 ﹤0.01% 3171
2014
Q2
$195K Buy
12,506
+1,233
+11% +$18.1K ﹤0.01% 2999
2014
Q1
$148K Buy
11,273
+271
+2% +$4.24K ﹤0.01% 3109
2013
Q4
$177K Sell
11,002
-1,424
-11% -$22.7K ﹤0.01% 2873
2013
Q3
$207K Buy
12,426
+1,090
+10% +$16.1K ﹤0.01% 2705
2013
Q2
$114K Buy
+11,336
New +$119K ﹤0.01% 3041

Other funds holding OSIR

American International Group's OSIR Position: Q2 2017 in Review

American International Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 10 shares.

American International Group first reported a position in OSIR in Q2 2013 and held it in 16 quarters. The position peaked at $219K in Q2 2015. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

  • American International Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • American International Group sold 10 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017.
  • American International Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • American International Group's Osiris Therapeutics, Inc. Common Stock position peaked at $219K in Q2 2015.
  • 3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.